Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-09-24
1984-08-07
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A01N 3702
Patent
active
044643926
ABSTRACT:
A process for using glycolic acid derivatives to control antimicrobial activity is disclosed. The process comprises: Contacting a microbe with an antimicrobial composition containing, as its active ingredient, a member selected from the group consisting of N,N-bis(pelargonoyloxyethyl)pelargonoyloxyacetamide, N,N-bis(lauroyloxyethyl)lauroyloxyacetamide, N,N-bis (oleoyloxyethyl)oleoyloxyacetamide, N,N-bis(trimethylacetyloxyethyl)trimethylacetylacetamide, carboethoxymethyl hydrocinnamate, and bis(carbomethoxymethyl) adipate.
REFERENCES:
patent: 2608577 (1952-08-01), Weesner
patent: 3089897 (1963-05-01), Balmer et al.
patent: 3567749 (1971-03-01), Neugebauer et al.
Bailey August V.
Boudreaux Gordon J.
Sumrell Gene
Goldberg Jerome D.
McConnell David
Rollins John W.
Silverstein M. Howard
The United States of America as represented by the Secretary of
LandOfFree
Process for controlling antimicrobial activity using glycolic ac does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for controlling antimicrobial activity using glycolic ac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for controlling antimicrobial activity using glycolic ac will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-603678